Eaton R P, Schade D S
Diabetologia. 1980 Apr;18(4):301-6. doi: 10.1007/BF00251010.
The relationship between non-esterified fatty acid (NEFA) mobilization and hepatic conversion to plasma triglycerides (TG), as modulated by diazoxide-induced effects upon endogenous catecholamine, glucagon, and insulin secretion, was examined in vivo in the rat. Thyrotropin (TSH)-induced NEFA mobilization provided the control study.--In all control experiments, TSH (1.5 IU/100 g) induced a 110% increase in NEFA availability, which was associated with a subsequent 52% increase in plasma TG concentration and a 73% increase in plasma ketone bodies. Following diazoxide administration (30 mg/kg), endogenous secretion of both catecholamines and glucagon was observed, resulting in a comparable 100% increase in NEFA availability, with the appropriate ketonaemic response. However, in contrast to the control TSH study, plasma triglyceride concentration did not increase. This suppression was secondary, at least in part, to a direct 40% inhibition of hepatic secretion of triglycerides.--Although plasma NEFA concentration is an important determinant of plasma triglyceride levels, the concurrent concentration of endogenous catecholamines, glucagon, and insulin modulate the hepatic conversion of NEFA to triglycerides in vivo.
在大鼠体内研究了由二氮嗪对内源性儿茶酚胺、胰高血糖素和胰岛素分泌的影响所调节的非酯化脂肪酸(NEFA)动员与肝脏将其转化为血浆甘油三酯(TG)之间的关系。促甲状腺激素(TSH)诱导的NEFA动员提供了对照研究。——在所有对照实验中,TSH(1.5 IU/100 g)使NEFA可用性增加了110%,这与随后血浆TG浓度增加52%以及血浆酮体增加73%相关。给予二氮嗪(30 mg/kg)后,观察到儿茶酚胺和胰高血糖素的内源性分泌,导致NEFA可用性有类似的100%增加,并伴有相应的酮血症反应。然而,与对照TSH研究不同的是,血浆甘油三酯浓度没有增加。这种抑制至少部分是由于肝脏甘油三酯分泌直接受到40%的抑制。——虽然血浆NEFA浓度是血浆甘油三酯水平的重要决定因素,但内源性儿茶酚胺、胰高血糖素和胰岛素的同时浓度在体内调节着NEFA向甘油三酯的肝脏转化。